FDA

Trump Administration Silences Federal Health Agencies: Public Health at Risk

The Trump administration, through HHS deputy chief of staff Stefanie Spear, has instructed federal health agencies, including the FDA, CDC, and NIH, to halt external communications. This sweeping order encompasses routine reports, website updates, and health advisories, with little explanation provided regarding its scope or duration. While temporary communication pauses are not unprecedented during transitions, the scale of this directive is unusual, raising concerns about potential delays in critical public health information dissemination. The timing is particularly notable given ongoing public health issues like the H5N1 bird flu outbreak.

Read More

FDA Bans Compounded Obesity Drugs: High Costs and Shortages Continue

Due to resolved shortages of Eli Lilly’s weight-loss and diabetes medications, Zepbound and Mounjaro, the FDA has ordered a phase-out of copycat versions sold by specialty and online pharmacies. This decision, effective within 60-90 days, benefits Lilly and potentially impacts patient access and costs. The FDA cited improved supply and safety concerns regarding the compounded drugs as reasons for the action. This reversal follows an earlier decision that was met with public opposition and legal challenge.

Read More

FDA Proposes Removing Ineffective Cold Medicine Phenylephrine from Market

The Food and Drug Administration has proposed removing oral phenylephrine, a common ingredient in over-the-counter cough and cold medicines, from the market due to its ineffectiveness as a nasal decongestant. This decision follows the agency’s own scientific review, which found that oral phenylephrine is poorly absorbed into the bloodstream and its effectiveness is questionable, contradicting earlier studies. The FDA is seeking public comment on this proposal, and if finalized, manufacturers will need to remove or reformulate products containing oral phenylephrine. While the FDA considers oral phenylephrine safe at current levels, it acknowledges that higher doses would be needed to achieve any meaningful effect, raising safety concerns.

Read More

Robert F. Kennedy Jr. Calls for FDA Abolition, Sparking Health Fears

Robert F. Kennedy Jr., a former presidential candidate and potential member of President-elect Donald Trump’s Cabinet, has called for the elimination of the Food and Drug Administration’s nutrition departments, citing their alleged failure to protect children from unhealthy food choices. He specifically criticizes the inclusion of numerous ingredients in U.S. products like Froot Loops, contrasting them with the simpler ingredients found in Canadian versions. Although Kennedy acknowledges the need for congressional approval, he plans to tackle perceived “corruption” within the FDA, believing that a healthier nation will result from reduced government interference. Trump has expressed support for Kennedy’s potential role in addressing health issues within the administration.

Read More

RFK Jr. Calls for FDA Overhaul, Sparking Fears of Public Health Crisis

Robert F. Kennedy Jr.’s potential appointment to a prominent position within the U.S. government, specifically overseeing public health, has sparked intense fear and outrage amongst many Americans. The concern stems from his outspoken skepticism surrounding vaccines and his ardent opposition to government regulations, which are seen as crucial for protecting public health.

RFK Jr.’s proposed role has prompted the fear that entire departments at the Food and Drug Administration (FDA) might be dismantled or radically restructured. This fear is rooted in the belief that under his leadership, the FDA, a vital agency responsible for ensuring the safety and efficacy of food, drugs, and medical devices, could become significantly weakened.… Continue reading

FDA rejects MDMA-assisted therapy for PTSD

The FDA recently made the decision to reject the use of MDMA-assisted therapy for the treatment of PTSD, citing a myriad of concerns including poorly designed studies and allegations of sexual misconduct. As someone who works in the clinical trial space, I understand the strict guidelines and the importance of well-designed studies when it comes to getting approval from regulatory bodies like the FDA. It’s clear that the issues within the studies conducted for MDMA therapy need to be addressed before any progress can be made.

The therapeutic potential of MDMA for individuals struggling with PTSD is undeniable. I’ve heard firsthand accounts of the emotional breakthroughs and healing that can occur when utilizing this drug in a therapeutic setting.… Continue reading

Supreme Court rejects bid to restrict access to abortion pill

As I reflect on the recent news that the Supreme Court has rejected a bid to restrict access to the abortion pill, I can’t help but feel a mix of relief and apprehension. The unanimous decision is a victory for reproductive rights, but the fact that the case was even brought to court highlights the ongoing threats to women’s autonomy and healthcare decisions.

The crux of the matter lies in the issue of legal standing. The court found that the group of anti-abortion doctors challenging the FDA’s decision on the abortion pill did not have the legal grounds to sue. While this is a win for now, it is not a definitive victory.… Continue reading

The FDA reverses its ban on Juul e-cigarettes

The FDA’s decision to reverse its ban on Juul e-cigarettes has stirred up mixed emotions and reactions from the public. For some, the news may come as a relief, especially for those who have found e-cigarettes to be a helpful tool in their journey towards quitting smoking. As a former smoker myself, I understand the struggle and the importance of having alternatives like e-cigarettes available.

However, the ban reversal raises questions about the effectiveness of such regulatory measures. While Juul has been under scrutiny for its marketing practices and the levels of nicotine in its products, the ban did not seem to address the root of the issue.… Continue reading

Ground cinnamon sold at discount stores is tainted with lead, FDA warns

As I sit here, I can’t help but feel a mixture of shock and disbelief after learning that ground cinnamon sold at discount stores is tainted with lead, as warned by the FDA. This news hit close to home for me personally since I recently purchased a container of cinnamon for my holiday baking and oatmeal spicing needs. Little did I know that I was unknowingly putting myself at risk of lead exposure by opting for the cheaper alternative available at these discount stores.

It’s unsettling to think about the potential health risks that come with consuming products that are contaminated with lead.… Continue reading